High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
Authors
Keywords
-
Journal
TRANSPLANT INTERNATIONAL
Volume 25, Issue 11, Pages 1158-1164
Publisher
Wiley
Online
2012-08-06
DOI
10.1111/j.1432-2277.2012.01540.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunosuppression and hepatocellular carcinoma
- (2011) Hans J. Schlitt et al. LIVER TRANSPLANTATION
- Treatment of recurrent hepatocellular carcinoma after liver transplantation
- (2011) Eric Davis et al. LIVER TRANSPLANTATION
- Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
- (2011) Carlos Gomez-Martin et al. LIVER TRANSPLANTATION
- A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
- (2010) Andreas A Schnitzbauer et al. BMC CANCER
- Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
- (2010) D. H. Yoon et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle
- (2010) Sherrie Bhoori et al. JOURNAL OF HEPATOLOGY
- Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection
- (2010) Richard Kim et al. MEDICAL ONCOLOGY
- Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
- (2010) Richard Kim et al. ONCOLOGY
- Sorafenib-Induced Severe Acute Hepatitis in a Stable Liver Transplant Recipient
- (2010) Uta Herden et al. TRANSPLANTATION
- Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
- (2010) A. Valdivieso et al. TRANSPLANTATION PROCEEDINGS
- Apparent Remission of a Solitary Metastatic Pulmonary Lesion in a Liver Transplant Recipient Treated with Sorafenib
- (2009) M. Yeganeh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
- (2009) Christian Toso et al. HEPATOLOGY
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
- (2009) Pippa Newell et al. JOURNAL OF HEPATOLOGY
- Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation
- (2009) Srinath Chinnakotla et al. LIVER TRANSPLANTATION
- Improved results of transplantation for hepatocellular carcinoma: A report from the international registry of hepatic tumors in liver transplantation
- (2009) Nicholas Onaca et al. LIVER TRANSPLANTATION
- Acute Hepatitis in a Patient With Cirrhosis and Hepatocellular Carcinoma Treated With Sorafenib
- (2008) Lucia Llanos et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Sorafenib-Induced Liver Failure
- (2008) AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2008) Z. Wang et al. CLINICAL CANCER RESEARCH
- Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation
- (2008) Jeong-Ok Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search